Jawahar Mehta (born August 10, 1946) is a board-certified Indian-born American cardiologist in Little Rock, Arkansas.
He is the Stebbins Chair and Professor of Medicine at the College of Medicine, University of Arkansas for Medical Sciences (UAMS).
Jawahar Mehta Facts
- Full Name: Jawahar L. Mehta
- Age: 76 years old
- Date of Birth: August 10, 1946
- Place of Birth: Kahrore, India
- Occupation: Cardiologist
- Nationality: American
- Wife: Paulette Mehta, MD
- Children: Asha Mehta and Jason Mehta
Jawahar Mehta Medical School & Residency
- Long Island Jewish Medical Center, Fellowship Hospital — 1975
- Mt Sinai-Beth Israel Hosp, Residency Hospital — 1973
- Grasslands Hosp-Ny Med Coll, Residency Hospital — 1971
- Grasslands Hosp-Ny Med Coll, Internship Hospital — 1970
- GN Med Coll, Amritsar, Punjab, Medical School — 1968
Jawahar Mehta Career
His first faculty role was at the University of Florida, where he ascended to the position of Professor of Medicine. In October 2000, he was appointed Stebbins Chair, Professor of Medicine, and Director of Cardiovascular Medicine at the University of Arkansas for Medical Sciences (UAMS) College of Medicine. He is currently an adjunct faculty member at the Clinton School of Public Service at the University of Arkansas.
Mehta was among the first at the University of Florida College of Medicine to describe platelet activation as a cause of acute coronary syndromes. Later, he demonstrated that platelets also protect the heart after ischemia via the release of transforming growth factor beta1. He co-directed the hypertension center at the University of Florida with Professor Ian Phillips. Current focus of his research is the uptake of oxidized low density lipoprotein (LDL) via LOX-1 receptors (OLR1).
Mehta has made contributions to the pathobiology of cardiovascular disorders through clinical and scientific studies (h index 101, 81,016 citations). His research on LOX-1 receptors, its polymorphic variations, and its function in atherogenesis and cardiac ischemia has led to the development of new therapeutic targets that are currently being investigated by a number of biotechnology companies, including MedImmune.
His affiliations include the American Society for Clinical Investigation, the American Association of Physicians, and the Association of University Cardiologists.
He is also the director of the Molecular Cardiology Program and an adjunct professor at the University of Rome, Tor Vergata.
Certifications & Licensure
- American Board of Internal Medicine – Certified in Cardiovascular Disease
- American Board of Internal Medicine – Certified in Internal Medicine
- NY State Medical License – Active through
- MN State Medical License – Active through 1976
- FL State Medical License – Active through 2002
- AR State Medical License – Active through 2022
- UAMS Medical Center, Little Rock, AR
Dr. Jawahar L Mehta has the following 32 areas of expertise
- Coronary Restenosis
- Heart Attack
- Coronary Artery Disease (CAD)
- Heart Diseases
- Heart Disease (Myocardial Ischemia)
- Arteriosclerosis (Arterial Disease)
- Metabolic Syndrome X
- Vascular Graft Occlusion
- Coronary Stenosis
- Unstable Angina
- Myocardial Infarction
- Coronary Artery Bypass (Heart Bypass)
- Gene Therapy
- Diabetes, Type 2
- Blood Clot
- Cardiovascular Disease
- Coronary Disease
- Coronary Artery Angioplasty & Stent
- Heart Failure
- Heart Block
- High Cholesterol
- Acute Coronary Syndrome (ACS)
- Left Ventricular Dysfunction
- Diabetes Complications
- Aetna Choice POS II
- Aetna HMO
- Aetna Managed Choice POS Open Access
- Aetna Signature Administrators PPO
- BCBS Blue Card PPO
- CIGNA HMO
- CIGNA Open Access Plus
- CIGNA PPO
- First Health PPO
- Humana Choice POS
- Humana ChoiceCare Network PPO
- UHC Choice Plus POS
- UHC Navigate HMO
- UHC Navigate POS
- UHC Options PPO
Location & Contact Information
John L Mcclellan Memorial VA Cardiology
4300 W 7th St Ste 111B-LR
Little Rock, AR 72205
Fax: (501) 125-7579
Data provided by the National Library of Medicine
- Proapoptotic effects of ANG II in human coronary artery endothelial cells: role of AT1 receptor and PKC activation.
Should fibrinogen be measured routinely in patients with unstable coronary heart disease?
- Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation.
- Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia-reoxygenation and angiotensin II: role of AT1 receptor activation.
- gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells.
- Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction.
- Antioxidants and vitamins in your cardiac patient: are they helpful?
- Role of TGF-beta1 in platelet-mediated cardioprotection during ischemia-reperfusion in isolated rat hearts.
- Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis.
- Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-beta(1).
- Tumor necrosis factor-alpha enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C.
- Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?
- Role of new risk factors in coronary artery disease.
Effect of stable fish oil on arterial thrombogenesis, platelet aggregation, and
- Carvedilol prevents epinephrine-induced apoptosis in human coronary artery
Jawahar Mehta Net Worth
Jawahar Mehta has an estimated net worth of $7 million.